Should I buy or sell Cresco Labs stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRLBF shares. View CRLBF analyst ratings or view top-rated stocks .

What is Cresco Labs' stock price target for 2024?

3 Wall Street analysts have issued 1-year price objectives for Cresco Labs' stock. Their CRLBF share price targets range from $2.00 to $34.00. On average, they expect the company's share price to reach $20.33 in the next twelve months. This suggests a possible upside of 868.3% from the stock's current price. View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts .

How have CRLBF shares performed in 2024?

Cresco Labs' stock was trading at $1.3558 at the beginning of the year. Since then, CRLBF shares have increased by 54.9% and is now trading at $2.10. View the best growth stocks for 2024 here .

Are investors shorting Cresco Labs?

Cresco Labs saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,759,900 shares, an increase of 28.7% from the February 29th total of 1,367,000 shares. Based on an average trading volume of 1,481,600 shares, the days-to-cover ratio is presently 1.2 days. View Cresco Labs' Short Interest .

When is Cresco Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024. View our CRLBF earnings forecast .

How were Cresco Labs' earnings last quarter?

Cresco Labs Inc. (OTCMKTS:CRLBF) released its quarterly earnings data on Friday, March, 15th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.03. The business earned $188.24 million during the quarter, compared to analysts' expectations of $181.36 million. Cresco Labs had a negative net margin of 22.77% and a negative trailing twelve-month return on equity of 10.51%.

How do I buy shares of Cresco Labs?

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free CRLBF Stock Alerts

$2.10

-0.09 (-4.11%)

(As of 04/18/2024 ET)

Compare

Today's Range: $2.06
▼
$2.20
50-Day Range: $1.52
▼
$2.30
52-Week Range: $1.00
▼
$2.77

Volume: 281,270 shs
Average Volume: 935,036 shs
Market Capitalization: $725.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $20.33

Stock Analysis Analyst Forecasts Chart Earnings Financials Headlines SEC Filings Short Interest

Get Cresco Labs alerts:

Cresco Labs MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 868.3% Upside
$20.33 Price Target
Short Interest: Healthy
0.52% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.20
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.07) to ($0.04) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.38 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Cresco Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Cresco Labs has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.52% of the outstanding shares of Cresco Labs have been sold short.
Short Interest Ratio / Days to Cover
Cresco Labs has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cresco Labs has recently increased by 1.22%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Cresco Labs does not currently pay a dividend.
Dividend Growth
Cresco Labs does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CRLBF.

2.1

News and Social Media Coverage

News Sentiment
Cresco Labs has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Cresco Labs this week, compared to 2 articles on an average week.
Search Interest
10 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.
MarketBeat Follows
19 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 90% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cresco Labs insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.05% of the stock of Cresco Labs is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Cresco Labs are expected to grow in the coming year, from ($0.07) to ($0.04) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cresco Labs is -3.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cresco Labs is -3.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cresco Labs has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Cresco Labs Stock (OTCMKTS:CRLBF)

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

CRLBF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CRLBF Stock News Headlines

April 18, 2024 | benzinga.com

Cannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?

April 17, 2024 | msn.com

Marijuana banking unlikely to pass House due to Republican leadership spat

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 17, 2024 | fool.com

The Best Cannabis Stock to Invest $1,000 in Right Now

April 9, 2024 | markets.businessinsider.com

Jefferies Remains a Buy on Cresco Labs (CRLBF)

March 28, 2024 | msn.com

2 Marijuana Companies That Have Recently Turned Profits

March 27, 2024 | investorplace.com

3 Cannabis Stocks to Buy Before the Coming Pre-Election Rally

March 20, 2024 | msn.com

Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy?

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 18, 2024 | investorplace.com

CRLBF Stock Earnings: Cresco Labs Beats EPS, Beats Revenue for Q4 2023

March 15, 2024 | morningstar.com

Cresco Labs' stock rallies as cannabis company swings to a profit

March 15, 2024 | seekingalpha.com

Cresco Labs Inc. (CRLBF) Q4 2023 Earnings Call Transcript

March 13, 2024 | markets.businessinsider.com

Needham Keeps Their Hold Rating on Cresco Labs (CRLBF)

March 13, 2024 | markets.businessinsider.com

Cresco Labs Turns To Profit In Q4

March 13, 2024 | msn.com

Cresco Labs’ stock rallies as cannabis company swings to a profit

March 13, 2024 | businesswire.com

Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements

February 27, 2024 | businesswire.com

Cresco Labs to Report Fourth Quarter and Annual 2023 Financial Results on March 13, 2024

February 24, 2024 | benzinga.com

Cannabis Stocks Jump As Germany Legalizes Marijuana Possession

February 23, 2024 | businesswire.com

Cresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg Store

February 21, 2024 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cresco Labs (OtherCRLBF), Medios AG (OtherMEDOF) and Bayer (GB:0P6S)

February 20, 2024 | benzinga.com

Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes

February 18, 2024 | investorplace.com

Cannabis Comeback: 3 Stocks to Snag After the Bubble Burst

February 9, 2024 | morningstar.com

Cresco Labs Inc CRLBF

February 9, 2024 | finance.yahoo.com

Cresco Labs Announces Transfers of Super Voting Shares to Certain Directors

February 9, 2024 | businesswire.com

Cresco Labs Announces Transfers of Super Voting Shares to Certain Directors

February 8, 2024 | markets.businessinsider.com

3 Cannabis Penny Stocks with Serious Potential to Make You a Millionaire

February 7, 2024 | benzinga.com

PA Gov Wants Cannabis Legalized, It's Time To Catch Up With Other States And Earn $250M In Revenue, He Says

See More Headlines

Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/15/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/22/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:CRLBF
CUSIP: N/A
CIK: 1832928
Web: www.crescolabs.com
Phone: 312-929-0993
Fax: N/A
Employees: 2,760
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $20.33
High Stock Price Target: $34.00
Low Stock Price Target: $2.00
Potential Upside/Downside: +868.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.54)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-175,520,000.00
Net Margins: -22.77%
Pretax Margin: -19.06%
Return on Equity: -10.51%
Return on Assets: -3.56%

Debt

Debt-to-Equity Ratio: 1.55
Current Ratio: 1.39
Quick Ratio: 0.85

Sales & Book Value

Annual Sales: $770.89 million
Price / Sales: 0.94
Cash Flow: $0.05 per share
Price / Cash Flow: 40.30
Book Value: $1.24 per share
Price / Book: 1.69

Miscellaneous

Outstanding Shares: 345,620,000
Free Float: N/A
Market Cap: $725.80 million
Optionable: Not Optionable
Beta: 2.29

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Thomas J. Manning (Age 68)
Executive Chairman of the Board
Comp: $800.05k
Mr. Charles Bachtell (Age 45)
Co-Founder, CEO & Director
Comp: $999.85k
Mr. Robert M. Sampson (Age 49)
Co-Founder & Independent Director
Mr. Dennis M. Olis (Age 61)
Chief Financial Officer
Comp: $622.85k
Mr. Gregory Butler (Age 43)
President & Chief Transformation Officer
Mr. Ty Gent (Age 65)
Chief Operating Officer
Mr. Zach Marburger (Age 39)
Chief Information Officer
Ms. Megan Kulick
Senior Vice President of Investor Relations
Mr. John Schetz (Age 46)
General Counsel
Mr. Jason Erkes (Age 53)
Chief Communications Officer

Key Competitors

View All Competitors

CRLBF Stock Analysis - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRLBF shares.
View CRLBF analyst ratings or view top-rated stocks.
What is Cresco Labs' stock price target for 2024?: 3 Wall Street analysts have issued 1-year price objectives for Cresco Labs' stock. Their CRLBF share price targets range from $2.00 to $34.00. On average, they expect the company's share price to reach $20.33 in the next twelve months. This suggests a possible upside of 868.3% from the stock's current price.
View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts.
How have CRLBF shares performed in 2024?: Cresco Labs' stock was trading at $1.3558 at the beginning of the year. Since then, CRLBF shares have increased by 54.9% and is now trading at $2.10.
View the best growth stocks for 2024 here.
Are investors shorting Cresco Labs?: Cresco Labs saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,759,900 shares, an increase of 28.7% from the February 29th total of 1,367,000 shares. Based on an average trading volume of 1,481,600 shares, the days-to-cover ratio is presently 1.2 days.
View Cresco Labs' Short Interest.

When is Cresco Labs' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024.
View our CRLBF earnings forecast.
How were Cresco Labs' earnings last quarter?: Cresco Labs Inc. (OTCMKTS:CRLBF) released its quarterly earnings data on Friday, March, 15th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.03. The business earned $188.24 million during the quarter, compared to analysts' expectations of $181.36 million. Cresco Labs had a negative net margin of 22.77% and a negative trailing twelve-month return on equity of 10.51%.
How do I buy shares of Cresco Labs?: Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CRLBF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cresco Labs (CRLBF) Stock Price, News & Analysis

Cresco Labs MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Cresco Labs Stock (OTCMKTS:CRLBF)

CRLBF Stock Price History

CRLBF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CRLBF Stock Analysis - Frequently Asked Questions

Overall MarketRank^™